Alpha Teknova (TKNO) Share-based Compensation (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Share-based Compensation of $5.3 million for Q1 2026, up 522.07% year-over-year from $852000.0 in Q1 2025, and up 582.11% quarter-over-quarter from $777000.0 in Q4 2025.
Alpha Teknova (TKNO) Share-based Compensation (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Share-based Compensation for 7 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 522.07% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 65.06% YoY), while the FY2025 annual figure was $4.6 million, up 25.48% from the prior year.
- Share-based Compensation improved to $5.3 million in Q1 2026 per TKNO's latest filing, from $777000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.3 million in Q1 2026 and bottomed at $385000.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $934000.0 in 2022.
- Annual changes were most pronounced in 2023 — Share-based Compensation plunged 62.33% — and 2026, when it jumped 522.07%.
- Alpha Teknova's Share-based Compensation stood at $1.0 million in 2022, then slumped by 62.33% to $385000.0 in 2023, then soared by 98.96% to $766000.0 in 2024, then grew by 1.44% to $777000.0 in 2025, then surged by 582.11% to $5.3 million in 2026.
- Business Quant data shows TKNO's Share-based Compensation at $5.3 million in Q1 2026, $777000.0 in Q4 2025, and $850000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 622,000.00 |
| Jun 30, 2026 | 622,000.00 |
| Mar 31, 2026 | 5.30 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Dec 31, 2025 | 777,000.00 |
| Dec 31, 2025 | 777,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Mar 31, 2025 | 852,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |